Synthetic Biology Platforms
Solugen
by Solugen Inc.
Chemienzymatic platform producing industrial chemicals from bio-based feedstocks at petrochemical scale and cost
Category
Synthetic Biology Platforms
Founded
2016
Headquarters
Houston, TX, USA
Overview
Solugen has developed a proprietary chemienzymatic manufacturing platform called Bioforge that combines engineered enzymes with chemical catalysis to convert plant-based sugars into high-value industrial chemicals. Unlike traditional fermentation, the chemienzymatic process operates at near-ambient temperatures and pressures in continuous flow reactors, achieving production efficiencies and costs competitive with petrochemical routes while using 90%+ bio-based carbon. Industrial customers in water treatment, oil and gas, agriculture, and construction materials purchase Solugen's products — including glucaric acid, hydrogen peroxide, and specialty chelating agents — as drop-in sustainable replacements for petroleum-derived chemicals. The Bioforge facility in Houston produces thousands of tons per year of these specialty chemicals, with the ability to rapidly reconfigure the platform to produce different chemical targets as market demand evolves. Solugen's key differentiator is the modular, reconfigurable nature of its Bioforge platform: by engineering enzymatic pathways as combinatorial modules, the company can switch product targets without rebuilding manufacturing infrastructure, providing flexibility that traditional fermentation or chemical synthesis cannot match. Backed by over $600 million in funding from investors including Baillie Gifford, GV, and Temasek, Solugen has been recognized as a technology pioneer capable of decarbonizing the $1.5 trillion industrial chemicals sector.
Key Features
Metabolic Modeling
Genome-scale metabolic models predict optimal genetic modifications for target compound production.
Biosecurity Screening
Automated screening of synthetic DNA orders against regulated pathogen sequences.
Organism Tracking & IP
Track engineered organisms with digital provenance records and intellectual property documentation.
Automated Strain Engineering
High-throughput strain construction combining robotic assembly with ML-guided genetic design.
Metabolic Pathway Design
Computational design of biosynthetic pathways for production of target compounds in engineered organisms.
Pros & Cons
Pros
- +Cell programming platform designs custom organisms for therapeutics, agriculture, and industrial biotechnology
- +Automated organism engineering combines high-throughput strain construction with ML-guided design
- +End-to-end platform from DNA design through fermentation optimization and process development
- +Metabolic modeling predicts optimal genetic modifications for target compound production
- +Proprietary strain libraries and genetic parts catalogs accelerate design-build-test-learn cycles
- +Bio-manufacturing partnerships enable commercial scale-up from prototype to production organisms
- +Foundry-scale automation processes thousands of genetic designs in parallel
Cons
- −Intellectual property landscape for genetic parts and engineered organisms is complex
- −Regulatory frameworks for engineered organisms vary globally and can delay commercialization
- −Scale-up from laboratory to commercial production introduces unpredictable biological challenges
- −Design-build-test-learn cycles still require weeks to months for complex organism engineering
Use Cases
Strain Engineering & Optimization
Automated organism engineering combining high-throughput strain construction with ML-guided metabolic design.
Biosynthetic Pathway Design
Computational design of metabolic pathways for production of target compounds in engineered organisms.
Fermentation Scale-Up
Data-driven optimization of fermentation conditions from lab-scale to commercial biomanufacturing.